HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 232 filers reported holding HERBALIFE LTD in Q1 2022. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398 | +10.2% | 28,430 | +26.9% | 0.03% | -5.6% |
| Q1 2023 | $361 | -30.2% | 22,400 | -35.5% | 0.04% | -43.8% |
| Q4 2022 | $517 | -99.9% | 34,752 | -14.2% | 0.06% | -40.2% |
| Q3 2022 | $806,000 | -55.5% | 40,515 | -54.3% | 0.11% | -60.7% |
| Q2 2022 | $1,811,000 | +100.8% | 88,573 | +301.8% | 0.27% | +140.7% |
| Q4 2021 | $902,000 | -55.1% | 22,043 | -53.5% | 0.11% | -44.9% |
| Q3 2021 | $2,011,000 | +439.1% | 47,442 | +510.6% | 0.20% | +236.1% |
| Q4 2020 | $373,000 | -25.5% | 7,770 | -26.1% | 0.06% | +5.2% |
| Q4 2019 | $501,000 | +117.8% | 10,511 | +73.2% | 0.06% | +87.1% |
| Q3 2019 | $230,000 | -65.2% | 6,069 | -60.7% | 0.03% | -58.1% |
| Q2 2019 | $661,000 | -84.5% | 15,454 | -80.8% | 0.07% | -82.9% |
| Q1 2019 | $4,265,000 | +106.5% | 80,478 | +129.7% | 0.43% | +81.5% |
| Q4 2018 | $2,065,000 | -54.4% | 35,036 | -57.8% | 0.24% | -4.8% |
| Q3 2018 | $4,533,000 | +59.5% | 83,091 | +57.1% | 0.25% | +77.3% |
| Q2 2018 | $2,842,000 | +13.5% | 52,898 | +105.8% | 0.14% | +6.0% |
| Q1 2018 | $2,505,000 | +1140.1% | 25,703 | +763.7% | 0.13% | +1008.3% |
| Q4 2017 | $202,000 | -37.3% | 2,976 | -34.1% | 0.01% | -42.9% |
| Q2 2017 | $322,000 | -85.3% | 4,518 | -88.0% | 0.02% | -82.2% |
| Q1 2017 | $2,190,000 | +15.2% | 37,676 | -4.6% | 0.12% | +3.5% |
| Q4 2016 | $1,901,000 | -26.3% | 39,487 | -5.1% | 0.11% | -18.0% |
| Q3 2016 | $2,580,000 | -22.4% | 41,614 | -26.8% | 0.14% | -24.5% |
| Q2 2016 | $3,326,000 | +25.2% | 56,821 | +31.7% | 0.18% | +8.9% |
| Q1 2016 | $2,656,000 | -31.1% | 43,142 | -40.0% | 0.17% | -10.6% |
| Q4 2015 | $3,856,000 | +24.7% | 71,917 | +26.7% | 0.19% | +24.3% |
| Q3 2015 | $3,092,000 | -8.8% | 56,740 | -7.8% | 0.15% | +16.9% |
| Q2 2015 | $3,389,000 | +81.7% | 61,515 | +41.0% | 0.13% | +75.7% |
| Q1 2015 | $1,865,000 | +71.3% | 43,615 | +51.0% | 0.07% | -2.6% |
| Q4 2014 | $1,089,000 | -62.1% | 28,892 | -56.0% | 0.08% | -49.7% |
| Q3 2014 | $2,870,000 | +138.4% | 65,592 | +251.5% | 0.15% | +179.6% |
| Q2 2014 | $1,204,000 | +24.8% | 18,658 | +52.1% | 0.05% | -28.9% |
| Q4 2013 | $965,000 | +101.9% | 12,264 | +79.0% | 0.08% | +100.0% |
| Q3 2013 | $478,000 | -23.6% | 6,852 | -50.6% | 0.04% | -48.6% |
| Q2 2013 | $626,000 | – | 13,875 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |